Abstract-Nitric oxide plays a pivotal role in regulating vascular tone. Different studies show endothelial function is impaired during hyperglycemia. Dark chocolate increases flow-mediated dilation in healthy and hypertensive subjects with and without glucose intolerance; however, the effect of pretreatment with dark chocolate on endothelial function and other vascular responses to hyperglycemia has not been examined. Therefore, we aimed to investigate the effects of flavanol-rich dark chocolate administration on (1) flow-mediated dilation and wave reflections; (2) blood pressure, endothelin-1 and oxidative stress, before and after oral glucose tolerance test (OGTT 1 Atherosclerotic pathology is a common sequela to T2DM, with macrovascular and microvascular diseases being among the leading causes of morbidity and mortality in patients with T2DM.
D
iets high in readily absorbable carbohydrates are associated with an increased risk for type 2 diabetes mellitus (T2DM). 1 Atherosclerotic pathology is a common sequela to T2DM, with macrovascular and microvascular diseases being among the leading causes of morbidity and mortality in patients with T2DM. 2 Even after adjustment for conventional risk factors, individuals with T2DM exhibit a 2-to 4-fold increased risk of mortality in comparison with individuals without diabetes. 3 Thus, several investigations have been directed to the potential adverse effects of hyperglycemia on the arterial wall. Observational data reveal high blood glucose concentrations are a risk factor for mortality, even in nondiabetic individuals. 4 Postprandial hyperglycemia has also been implicated in the development of cardiovascular disease. Elevated postprandial glucose may have a direct toxic effect on the vascular endothelium mediated by oxidative stress, independent of other cardiovascular risk factors, such as hyperlipidemia. 2, 5 A highcarbohydrate meal has been described to increase oxidative stress and favor proinflammatory effects. 5 Several in vivo studies have found impaired nitric oxide (NO)-mediated endothelial function during acute episodes of hyperglycemia. [6] [7] [8] [9] [10] NO is a key endothelium-derived relaxing factor and plays a pivotal role in the maintenance of basal vascular tone and vascular responses to dilative stimuli. [11] [12] [13] NO acts to negate the actions of endothelium-derived contracting factors such as angiotensin II and endothelin-1 (ET-1), as well as inhibit platelet aggregability [11] [12] [13] and endothelial activation. [11] [12] [13] Therefore, reduced NO bioavailability may contribute to the onset and progression of endothelial dysfunction, including impaired vasodilative and increased adhesive properties, leading to atherogenesis. [11] [12] [13] Additionally, endothelium-derived NO may act to regulate arterial stiffness and wave reflec-tions. 13, 14 Reversal of endothelial dysfunction has been suggested to slow the rate of atherogenesis and improve the prognosis of patients with cardiovascular disease. [13] [14] [15] Consumption of dietary flavonoids, including intake from flavonoid-rich foods such as tea, wine, and cocoa has been linked to reduced endothelial dysfunction and increased resistance of low-density lipoprotein cholesterol to oxidation. 15, 16 Flavonoids appear to affect endothelial function by serving as antioxidants and as modulators of signal transduction pathways. 15, 16 We observed that flavanol-rich dark chocolate (DC) ingestion improves NO-dependent flow-mediated dilation (FMD) and insulin sensitivity and decreases blood pressure (BP) in healthy 17 and hypertensive subjects with 18 and without 19 glucose intolerance. Similarly, in patients with T2DM, Balzer et al 20 have reported that acute as well as thrice-daily consumption for 30 days of flavanol-containing cocoa increased FMD in a dose-dependent manner; however, the effect of pretreatment with flavonoids on the endothelial response to hyperglycemia has not yet been tested. Therefore, we hypothesized DC could be able to protect arterial function from a glucose load and examined the effects of DC and flavanol-free white chocolate (WC) administration for 3 days on endothelial function and wave reflections, as well as BP, circulating ET-1 and total isoprostanes (8-iso-PGF 2␣ ) before and after an oral glucose tolerance test (OGTT) in healthy subjects.
Methods

Subjects
Twelve healthy volunteers (5 males, mean age 28.2Ϯ2.7 years) were recruited from staff at the San Salvatore Regional Hospital and University of L'Aquila. Individuals were excluded if they had an acute or chronic disease, including any type of metabolic abnormality and/or major cardiovascular risk factor. Habitual smokers and use of any prescribed medication and/or dietary supplement within 2 weeks of entering the study were excluded. To further limit potential confounding factors, individuals were excluded if they reported daily intense sports activities (Ͼ10 hours/wk), changes of Ͼ10% body weight within 6 months of entering the study, current dietary treatment regimen, and/or participation in another clinical study within 3 months of entering this trial. The study was approved by the responsible Ethics Committee, and all participants gave written informed consent.
Study Design
After a 7-day, cocoa-free, run-in phase, the volunteers were randomly assigned to receive either 100-g DC bars (Cioccolato Bonajuto, Antica Dolceria Bonajuto) or 100-g WC bars (Milka, Kraft Foods) in an isocaloric fashion over a period of 3 days. FMD; office systolic (SBP) and diastolic (DBP) BP; pulse contour analysis for measuring stiffness index (SI), reflection index (RI), and peak-to-peak time (PPT); serum ET-1 and 8-iso-PGF 2␣ were evaluated before and after OGTT following each intervention phase. The homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and insulin sensitivity index were calculated from OGTT results.
After evaluation of exclusion/inclusion criteria, volunteers were carefully instructed to maintain their usual diet except to refrain from flavonoid-rich foods and beverages (a detailed list was given to each participant), including wine, as well as all other alcoholic beverages. All participants were encouraged to continue with their usual physical activity throughout the study period. The subjects were instructed to consume their chocolate bars in the morning and not in the afternoon or at dinner. They consumed the first dose at breakfast on day 1 and the last dose on the day before the visit. Analysis of the DC using high-performance liquid chromatography quantified 447 mg of epicatechin, 59 mg of catechin, and 14 mg of quercetin; the same method showed WC contained only trace amounts of polyphenols (0.04 mg of catechin). DC and WC contained similar amounts of energy and macronutrients (online-only Data Supplement Table S1 ). At the end of the first phase of intervention, patients entered a second 7-day, chocolate-free phase and then were crossed over to the other treatment. Chocolate doses for each subject were rolled in aluminum foil and administered in dated, sequentially numbered, nontransparent boxes that were not labeled regarding content. All the involved physicians and staff were blinded to the group assignment. Patients did not receive any information regarding the chocolate and were instructed not to disclose their assigned intervention group to investigators until the study completion. To avoid changes in body weight during the intervention, participants were carefully instructed on how to substitute the chocolate bars with foods of similar energy and macronutrient composition. Patients were continuously and carefully followed with tailored personal diet counseling provided throughout the study by trained dieticians and physicians. Please see the online-only Data Supplement for the additional and detailed methods section.
Results
According to the inclusion/exclusion criteria, participants presented with normal ranges for waist circumference, lipid profiles, and glucose-insulin metabolism. The baseline clinical characteristics of the 12 study subjects are shown in the online-only Data Supplement Table S2 . All subjects completed both parts of the study. 
Endothelial Function
Wave Reflections
Compared with the WC phase, DC ingestion decreased baseline SI ( Figure 2A) and RI values (59.3Ϯ12.4 versus 50.4Ϯ8%; Pϭ0.04) and increased PPT (265.5Ϯ35.1 versus 295.6Ϯ36.2 ms; Pϭ0.05). After WC, SI increased after the glucose load ( Figure 2B ). After DC, SI increased only after 60 minutes from glucose load. Similarly, after WC, RI increased after 30, 60, and 90 minutes, and PPT decreased after 30, 60, 90, 120, and 180 minutes from the glucose load, while, after DC, RI increased after 90 minutes, and PPT decreased after 60, 90, and 180 minutes (online-only Data Supplement Figures S1A and S1B, respectively). The DC attenuated the impairment of these measures of wave reflection induced by acute hyperglycemia (SI: Pϭ0.0089 for treatment; RI: Pϭ0.032 for treatment; PPT: PϽ0.0001 for treatment) (Figure 2 and onlineonly Data Supplement Figure S1 ). 
Blood Pressure
Endothelin-1
Baseline serum ET-1 level was higher after the WC compared with the DC intervention phase ( Figure 3A) . After the WC phase, ET-1 increased from 5.9Ϯ1.3 at baseline to 6.4Ϯ1.7 (Pϭ0.049), 6.5Ϯ1.4 (Pϭ0.011), 6.9Ϯ1.5 (PϽ0.0001), 7.2Ϯ1.5 (PϽ0.0001), and 7.3Ϯ1.5 pg/mL (PϽ0.0001) at 30, 60, 90, 120, and 180 minutes after the glucose load, respectively. In contrast, DC ingestion prevented the increase in ET-1 (Pϭ0.0023 for treatment) induced by the glucose load ( Figure 3B ).
Total Isoprostanes
Baseline concentrations of serum 8-iso-PGF 2␣ were higher after the WC compared with the DC intervention phase 
Insulin Resistance and ␤-Cell Function
Although a trend toward improvement was noted after DC but not WC ingestion, no significant differences were observed regarding glucose and insulin responses during the OGTT, homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and homeostatic model assessment %␤ (data not shown). 
Discussion
Our results show that, in healthy subjects, short-term treatment with flavanol-rich DC, compared with a dietary control of flavanol-free WC, was able to increase endotheliumdependent vasodilation and reduce wave reflections, lipid peroxidation, and ET-1 levels, also protecting from acute vascular alterations induced by a glucose load. Although we did not examine the mechanism(s) of action underlying this effect of DC, we might postulate that the cocoa flavanols in DC blunted the production or action of reactive oxygen species (ROS) induced by the transient hyperglycemia and subsequently decreased bioavailability of NO. ROS rapidly combines with NO to decrease its bioavailability and impair normal endothelial function by disrupting the balance between vasodilating and vasoconstricting factors. 6, 12, 15 Further, the measurement of 8-iso-PGF 2␣ , formed nonenzymatically through free radical catalyzed attack on esterified arachidonate, provides a reliable tool for identifying populations with enhanced rates of lipid peroxidation. Indeed, enhanced formation of 8-iso-PGF 2␣ has been reported in association with several cardiovascular risk factors. Accordingly, it has been suggested that 8-iso-PGF 2␣ may transduce oxidant stress-dependent platelet activation and endothelial dysfunction. 21 Data suggest the relationship between flavonoids and other dietary antioxidants, oxidative stress, and hyperglycemia may result from reduced NO degradation by ROS, 6, 9, 15, 22 increased endothelial NO synthase activity, 15, 20, 23 and/or decreased ET-1.
15,24,25
Impaired endothelium-dependent vasodilation and, by extension, decreased bioavailability of NO has been demonstrated in animal models of diabetes mellitus and in patients with both type 1 and type 2 diabetes. 6, 26 Augmented generation of ROS as a cause of this endothelial dysfunction has been implicated by studies in healthy humans 6, 9 and in patients with type 1 and type 2 diabetes in whom infusions of the antioxidant vitamin C restored endothelium-dependent vasodilation toward normal. 9, 27, 28 One feature common to the in vitro, animal, and human studies of diabetes is elevated glucose status. Indeed, hyperglycemia per se has been observed to negatively affect endothelium-dependent vasodilation in human arteries, 10 increase pulse wave reflections, and decrease aortic distensibility in healthy male volunteers. 29 Modest increases in postprandial glucose can acutely lower FMD in healthy subjects as well as those with impaired glucose tolerance and T2DM, though the latter groups show greater reductions. 7, 8 Consistent with our results, the inverse association between FMD and plasma glucose found in these studies suggests a continuous relationship between increasing glucose concentrations and decreasing endothelial function.
In vitro studies indicate that the exposure of endothelial cells to elevated glucose concentrations leads to the generation of ROS, including superoxide anion, which can inactivate NO or otherwise contribute to endothelial cell injury. 30 Similarly, patients with T2DM have increased concentrations of biomarkers of lipid peroxidation and reduced levels of endogenous antioxidants compared with healthy controls. 9 It has also been shown that an acute oral glucose load can increase biomarkers of oxidative stress in healthy subjects. 8 Concordantly, a recent study 31 reported that oxidative stress may be an early event in a metabolic cascade elicited by a high-glycemic index diet, ultimately increasing the risk for cardiovascular disease and diabetes. Our results suggest that hyperglycemia induced by an oral glucose load may increase oxidative stress, produce a transient loss of NO bioavailability, and an increase in ET-1, with a consequent impairment in vascular tone. Importantly, these data also suggest that cocoa flavanols may interfere with this chain of events.
This positive effect by cocoa flavanols might have important implications, as data on endothelial dysfunction obtained from coronary and upper arm circulation predicts coronary and cerebrovascular events. 12 Endothelium-derived NO and ET-1 also appear to play an important role in the regulation of arterial stiffness and wave reflections. [12] [13] [14] Arterial stiffness and wave reflections have also been shown to have an independent predictive value for cardiovascular morbidity and all-cause mortality and coronary events and strokes in patients with uncomplicated essential hypertension. 32 Flavanols and related polyphenolic antioxidants may protect against hyperglycemia by decreasing the formation of ROS and thereby increasing the bioavailability of NO. For example, Schroeter et al 23 reported that flavanol-rich cocoa improved FMD in conduit arteries and in microcirculation strongly correlated with the kinetics of increased NO species and (Ϫ)-epicatechin and its metabolites in plasma. They also found the actions of the cocoa flavanols were closely mimicked by pure (Ϫ)-epicatechin and abolished by the NO synthase inhibitor, L-N G -mono-methyl-arginine. Our data are concordant with our previous work [17] [18] [19] and other human studies showing a positive effect of flavanol-rich chocolate or cocoa on FMD. 15, 20, 33, 34 Similarly, Vlachopoulos et al 35 reported that 100-g, flavonoid-rich DC acutely increased FMD and decreased wave reflections, whereas it did not affect aortic stiffness. In contrast with our results, plasma oxidant status did not change after DC. Moreover, differently from our previous findings, [17] [18] [19] no variation in BP was observed between the active and control treatments. This incongruence might be explained, considering that the current study design involved a small number of subjects (according to our primary outcome: FMD) and the very short intervention phases (acute administration). Indeed, concordantly with all our findings, a very recent meta-analysis reported that, although FMD was improved after chronic and acute flavonoid-rich DC intakes, significant reductions in DBP and mean arterial pressure were observed after chronic but not after acute intake of DC. 36 Inherent limitations of our study design include the small number of subjects, short duration, and the inability to blind the participants to the test and control chocolate interventions. Our isocaloric protocol can also be considered a limitation in that it does not necessarily reflect usual patterns of chocolate consumption. Indeed, in the current study, we provided Ϸ25% of total daily calories by chocolate. Nevertheless, chocolate perfectly respects the daily recommended balance of macronutrient intake (protein: 10% to 35%; fat: 20% to 35%; carbohydrates: 45% to 65%), without negatively affecting the caloric quality of nutrients. Further, considering our previous findings, we aimed to test effects from commercial chocolate while preserving high flavonoids intake. Starting from this, future long-term studies should test and confirm the beneficial effects of DC at lower doses with reduced caloric burden but preserving the original high content of flavonoids, particularly, including DC in the usual dietary patterns of the population.
Our choice of interventions, however, did permit us to compare flavonoid-rich versus flavonoid-free chocolate and, simultaneously, cocoa-rich versus cocoa-free chocolate. This is of interest, as additional mechanisms of action of cocoa flavanol appear to exist (eg, via modulation of the reninangiotensin system), 37 and other cocoa constituents such as theobromine and caffeine may also contribute partly to the observed changes in FMD and wave reflections. One study of theobromine from dark chocolate, however, found no hemodynamic or electrophysiological effects in young adults 38 ; another found the caffeine and theobromine content of flavanolpoor chocolate were similar to that of flavanol-rich chocolate, although only dark chocolate affected vascular function and NO bioavailability, 39 and van den Bogaard et al 40 reported naturaldose theobromine cocoa did not significantly change either 24-hour ambulatory or central SBP compared with placebo.
Perspectives
We observed for the first time that consumption of flavanol-and cocoa-rich DC increases FMD together with a reduction of wave reflections and ET-1. The DC intervention attenuated the endothelial dysfunction, oxidative stress, and wave reflections induced by a glucose load in healthy subjects with normal glucose tolerance. Although our study design was robust, it was also short-term, involved a small number of subjects, and employed an isocaloric protocol. Importantly, caution is always warranted before recommending the addition of any calorie-rich food to the diet. Our results suggest that postprandial hyperglycemia may contribute substantially to atherosclerotic disease and that cocoa and flavanols might reduce the impact of this relationship. As worldwide cocoa and chocolate are daily consumed by the general population, our observations may have an impact on human health with important clinical consequences. 
